Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  2006-03-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/JAMA.295.12.1379PMID 16551709
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic risk assessment and BRCA mutation testing.

  2006cited by this paper
• Functional and genomic approaches reveal an ancient CHEK2 allele associated with breast cancer in the Ashkenazi Jewish population.

  2005influential reference
• Prevalence of five previously reported and recurrent BRCA1 genetic rearrangement mutations in 20,000 patients from hereditary breast/ovarian cancer families

  2005cited by this paper
• Pathology of breast cancer in women with constitutional CHEK2 mutations

  2005cited by this paper
• MRI surveillance for hereditary breast-cancer risk.

  2005cited by this paper
• Evolutionary conservation analysis increases the colocalization of predicted exonic splicing enhancers in the BRCA1 gene with missense sequence changes and in-frame deletions, but not polymorphisms

  2005cited by this paper
• Genomic rearrangements in the BRCA1 and BRCA2 genes

  2005cited by this paper
• Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers.

  2005cited by this paper
• Large genomic deletions inactivate the BRCA2 gene in breast cancer families

  2005cited by this paper
• Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Systematic Evidence Review for the U.S. Preventive Services Task Force

  2005cited by this paper
• Breast cancer predisposing alleles in Poland

  2005cited by this paper
• Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies

  2005cited by this paper
• A new alternative splice variant of BRCA1 containing an additional in-frame exon.

  2005cited by this paper
• Association of two mutations in the CHEK2 gene with breast cancer

  2005cited by this paper
• BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases

  2005cited by this paper
• Large genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast/ovarian cancer phenotype in selected families

  2005cited by this paper
• The Alu insertion in the CLCN5 gene of a patient with Dent's disease leads to exon 11 skipping

  2005cited by this paper
• Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.

  2005influential reference
• CHEK2 variant I157T may be associated with increased breast cancer risk

  2004cited by this paper
• BRCA1 and BRCA2 mutations in women with familial or early‐onset breast/ovarian cancer in the Czech Republic

  2004cited by this paper
• Minimal conditions for exonization of intronic sequences: 5' splice site formation in alu exons.

  2004cited by this paper
• Breast cancer: role of polymorphisms in biotransformation enzymes

  2004cited by this paper
• Large BRCA1 gene deletions are found in 3% of German high‐risk breast cancer families

  2004cited by this paper
• Significant Contribution of Germline BRCA2 Rearrangements in Male Breast Cancer Families

  2004cited by this paper
• Limited relevance of the CHEK2 gene in hereditary breast cancer

  2004cited by this paper
• CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies.

  2004cited by this paper
• A novel founder CHEK2 mutation is associated with increased prostate cancer risk.

  2004cited by this paper
• TCIRG1‐dependent recessive osteopetrosis: Mutation analysis, functional identification of the splicing defects, and in vitro rescue by U1 snRNA

  2004cited by this paper
• CHEK2 is a multiorgan cancer susceptibility gene.

  2004cited by this paper
• AluElements: Repetitive DNA as Facilitators of Chromosomal Rearrangement.

  2004cited by this paper
• CHEK2 variants associate with hereditary prostate cancer

  2003cited by this paper
• The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families.

  2003cited by this paper
• Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method.

  2003cited by this paper
• ESEfinder: a web resource to identify exonic splicing enhancers

  2003cited by this paper
• Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway.

  2003cited by this paper
• RNA analysis of eight BRCA1 and BRCA2 unclassified variants identified in breast/ovarian cancer families from Spain

  2003cited by this paper
• Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families.

  2003cited by this paper
• Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility.

  2003cited by this paper
• Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in israel.

  2003cited by this paper
• Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2

  2003influential reference
• Mutations in CHEK2 associated with prostate cancer risk.

  2003cited by this paper
• BRCA2 T2722R is a deleterious allele that causes exon skipping.

  2002cited by this paper
• Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

  2002influential reference
• Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.

  2002cited by this paper
• The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors

  2002cited by this paper
• Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families

  2002cited by this paper
• Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.

  2002cited by this paper
• Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations

  2002cited by this paper
• Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers.

  2001cited by this paper
• Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

  2001cited by this paper
• Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.

  2001cited by this paper
• Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.

  2001cited by this paper
• A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes

  2001cited by this paper
• Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites

  2001cited by this paper
• Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.

  2001cited by this paper
• Will the real Cowden syndrome please stand up: revised diagnostic criteria

  2000cited by this paper
• Frequency of BRCA1/BRCA2 mutations in a population‐based sample of young breast carcinoma cases

  2000cited by this paper
• Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing.

  2000cited by this paper
• BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer.

  2000cited by this paper
• Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer.

  1999cited by this paper
• Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.

  1998cited by this paper
• Germline mutations in PTEN are an infrequent cause of genetic predisposition to breast cancer

  1998cited by this paper
• Frequency of breast cancer attributable to BRCA1 in a population-based series of American women.

  1998cited by this paper
• The role of MMAC1 mutations in early-onset breast cancer: causative in association with Cowden syndrome and excluded in BRCA1-negative cases.

  1997cited by this paper
• Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.

  1997cited by this paper
• Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis.

  1997cited by this paper
• Recommendations for follow-up care of individuals with an inherited predisposition to Cancer. II. BRCA1 and BRCA2

  1997cited by this paper
• BRCA1 mutations in a population-based sample of young women with breast cancer.

  1996cited by this paper
• The Cowden syndrome: a clinical and genetic study in 21 patients

  1986cited by this paper
• Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?

  1969cited by this paper

• Hereditary ovarian cancer

  2026cites this paper
• Prioritising human rights principles in synthetic biology innovation and patenting

  2026cites this paper
• Characterization of Large Genomic Rearrangements in BRCA1 and BRCA2 Genes in a Chinese High-Risk Cohort.

  2026cites this paper
• Multigene germline and somatic testing for epithelial ovarian cancer in China

  2025cites this paper
• Advances in Breast Cancer Detection: Biomarkers, Mechanisms, and Biosensor Technologies.

  2025cites this paper
• The Application of Nanomaterials in Breast Cancer

  2025cites this paper
• Genetic regulation of the estrogen receptor and inherited predisposition to breast cancer.

  2025cites this paper
• Germline Mutations in DNA Repair Genes in Patients with Pancreatic Neuroendocrine Neoplasms: Diagnostic and Therapeutic Implications

  2025cites this paper
• The role of Alu elements in causing BRCA1 structural variation and breast cancer susceptibility

  2025cites this paper
• Metabolic Reprogramming and Adaption in Breast Cancer Progression and Metastasis.

  2025cites this paper
• The Spectrum of Disease-Associated Alleles in Countries with a Predominantly Slavic Population

  2024cites this paper
• Navigating the Complexity of PI3K/AKT Pathway in HER-2 Negative Breast Cancer: Biomarkers and Beyond.

  2024cites this paper
• BRCA1/2 Testing Landscape in Ovarian Cancer: A Nationwide, Real-World Data Study

  2024cites this paper
• Comprehensive genomic evaluation of advanced and recurrent breast cancer patients for tailored precision treatments

  2024cites this paper
• Advancements in targeting tumor suppressor genes (p53 and BRCA 1/2) in breast cancer therapy

  2024cites this paper
• Effects of BRCA1 overexpression via the NRF2 / HO1 / NQO1 pathway on oral cancer cells proliferation, migration, and apoptosis

  2024cites this paper
• Clinically Significant BRCA1 and BRCA2 Germline Variants in Breast Cancer—A Single-Center Experience

  2024cites this paper
• An ultra-sensitive and rapid immunosensor for the onsite detection of circulating tumor DNA in breast cancer

  2024cites this paper
• Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In Oncology.

  2024cites this paper
• Non-vesicular nanocarriers for breast cancer management: current advances, challenges, and future perspective

  2024cites this paper
• GENES BRCA1 E BRCA2 COMO BIOMARCADORES EM CARCINOMAS MAMÁRIOS CANINOS – REVISÃO DE LITERATURA

  2024cites this paper
• A Molecular Voyage: Multiomics Insights into Circulating Tumor Cells.

  2024cites this paper
• Understanding genetic variations associated with familial breast cancer

  2024cites this paper
• PARP inhibitors suppress tumours via centrosome error-induced senescence independent of DNA damage response

  2024cites this paper
• Enhancing PARP inhibitor efficacy using reduction-responsive nanoparticles encapsulating NADP.

  2024cites this paper
• Carrying SNP rs17506395 (T > G) in TP63 gene and CCR5Δ32 mutation associated with the occurrence of breast cancer in Burkina Faso

  2024cites this paper
• Methylation status of potential genes in breast cancer patients and correlate them with gene expression

  2023cites this paper
• Relationship of the expression of the NF1, p53, bcl-2, pRB proteins with DNA/RNA of viruses and mutations of the BRCA 1/2 and hMSH2 genes in liver cancer

  2023cites this paper
• Germline TP53 pathogenic variants and breast cancer: A narrative review.

  2023cites this paper
• Possible impact of HLA class I and class II on malignancies driven by a single germ‐line BRCA1 mutation

  2023cites this paper
• Rank-based Bayesian clustering via covariate-informed Mallows mixtures

  2023cites this paper
• Detection of clinically important BRCA gene mutations in ovarian cancer patients using next generation sequencing analysis.

  2023cites this paper
• Mutational Signatures in Gastric Cancer and Their Clinical Implications

  2023cites this paper
• Molecular profiling of BRCA1 and BRCA2 genes in Turkish patients with early-onset breast cancer

  2023cites this paper
• Peptide Vaccines as Therapeutic and Prophylactic Agents for Female-Specific Cancers: The Current Landscape

  2023cites this paper
• Penetrance of CHEK2 and BRCA1 Double Heterozygotes in Breast and/or Ovarian Cancer Patients

  2023cites this paper
• Racial disparities in cancer care, an eyeopener for developing better global cancer management strategies

  2023cites this paper
• Defining the heterogeneity of unbalanced structural variation underlying breast cancer susceptibility by nanopore genome sequencing

  2023cites this paper
• Involvement of ERCC1 (rs3212986) and ERCC2 (rs1799793, rs13181) polymorphisms of DNA repair genes in breast cancer occurrence in Burkina Faso

  2023cites this paper
• Genetic Testing for Hereditary Breast and Ovarian Cancer and

  2023cites this paper
• Molecularly Targeted Therapies for Triple Negative Breast Cancer: History, Advances, and Future Directions.

  2023cites this paper
• Radiation Therapy in Patients with Germline Mutations: a Review of the Current Evidence

  2023cites this paper
• Sitting in class

  2022cites this paper
• Importance of multigene panel test in patients with consanguineous marriage and family history of breast cancer

  2022cites this paper
• The emerging roles of NGS in clinical oncology and personalized medicine.

  2022cites this paper
• Spectrum of BRCA1/2 Mutations in Romanian Breast and Ovarian Cancer Patients

  2022cites this paper
• A bibliometric analysis of the top 100 most cited papers and research trends in breast cancer related BRCA1 and BRCA2 genes

  2022cites this paper
• Peptide-Based Vaccines in Clinical Phases and New Potential Therapeutic Targets as a New Approach for Breast Cancer: A Review

  2022cites this paper
• TP53 Pathogenic Variants in Early-Onset Breast Cancer Patients Fulfilling Hereditary Breast and Ovary Cancer and Li-Fraumeni-like Syndromes

  2022cites this paper
• Genetic testing for hereditary predisposition to breast cancer in the real world: Initial experience

  2022cites this paper
• Unsupervised ensemble learning for genome sequencing

  2022cites this paper
• Spectrum of germline pathogenic variants using a targeted next generation sequencing panel and genotype-phenotype correlations in patients with suspected hereditary breast cancer at an academic medical centre in Pakistan

  2022cites this paper
• Identification of hereditary breast and ovarian cancer germline variants in Granada (Spain): NGS perspective

  2022cites this paper
• A Novel Gene Prognostic Signature Based on Differential DNA Methylation in Breast Cancer

  2021cites this paper
• Development and validation of polygenic risk scores for prediction of breast cancer and breast cancer subtypes in Chinese women

  2021cites this paper
• Complex Genetic Interactions/Data Mining/Dimensionality Reduction

  2021cites this paper
• Hereditary Cancers and Genetics

  2021cites this paper
• Familial Breast Cancer: Disease Related Gene Mutations and Screening Strategies for Chinese Population

  2021influential citation
• Medical guidelines for Li–Fraumeni syndrome 2019, version 1.1

  2021cites this paper
• Imaging the Symptomatic Breast in the Pediatric, Young, Pregnant, Lactating, and Transgender Patient

  2021cites this paper
• Transposons: Unexpected players in cancer.

  2021cites this paper
• Identification of Candidate Genes in Early-Stage Invasive Ductal Carcinoma Patients with High-Risk Mortality Using Genes Commonly Involved in Breast Cancer: A Retrospective Study

  2021cites this paper
• Breast Cancer Predisposition Genes and Synthetic Lethality

  2021cites this paper
• Prevalence and predictors of germline BRCA1 and BRCA2 mutations among young patients with breast cancer in Jordan

  2021cites this paper
• CHEK2 Pathogenic Variants in Greek Breast Cancer Patients: Evidence for Strong Associations with Estrogen Receptor Positivity, Overuse of Risk-Reducing Procedures and Population Founder Effects

  2021cites this paper
• Computational and Artificial Intelligence Techniques for Drug Discovery and Administration

  2021cites this paper
• Rare Coding Variants Associated with Breast Cancer.

  2021cites this paper
• ANKLE1 as New Hotspot Mutation for Breast Cancer in Indian Population and Has a Role in DNA Damage and Repair in Mammalian Cells

  2021cites this paper
• The results of multigene panel sequencing in Slovak HBOC families.

  2021cites this paper
• Germline Structural Variations in Cancer Predisposition Genes

  2021cites this paper
• How Have Multigene Panels Changed the Clinical Practice of Genetic Counseling and Testing.

  2021cites this paper
• Breast Cancer Genetics

  2021cites this paper
• The role of microbial pathogens in cancer development: a potential guide to anticancer drugs

  2020cites this paper
• Targeting the splice factor kinase CLK1 in prostate cancer cells

  2020cites this paper
• The importance of molecular genetics for cancer screening

  2020cites this paper
• How a little logic could have corrected long-held misbeliefs

  2020cites this paper
• Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple Negative Breast Cancer.

  2020cites this paper
• CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate

  2020cites this paper
• National Comprehensive Cancer Network

  2020cites this paper
• Knockdown of LINC00665 inhibits proliferation and invasion of breast cancer via competitive binding of miR-3619-5p and inhibition of catenin beta 1

  2020cites this paper
• Bilateral Disease Common Among Slovenian CHEK2-Positive Breast Cancer Patients

  2020cites this paper
• Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population

  2020cites this paper
• MAGPEL: an autoMated pipeline for inferring vAriant-driven Gene PanEls from the full-length biomedical literature

  2020cites this paper
• Clinicopathological characteristics of gene-positive breast cancer in the United Arab Emirates

  2020cites this paper
• Evaluating polygenic risk scores in assessing risk of nine solid and hematologic cancers in European descendants

  2020cites this paper
• CHEK2 Gene

  2020cites this paper
• Complex Characterization of Germline Large Genomic Rearrangements of the BRCA1 and BRCA2 Genes in High-Risk Breast Cancer Patients—Novel Variants from a Large National Center

  2020cites this paper
• Screening of BRCA1/2 genes mutations and copy number variations in patients with high risk for hereditary breast and ovarian cancer syndrome (HBOC)

  2020cites this paper
• BRCA1 Gene

  2020cites this paper
• Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of Patients

  2020cites this paper
• The contribution of large genomic rearrangements in BRCA1 and BRCA2 to South African familial breast cancer

  2020cites this paper
• Naturally-Occurring Canine Mammary Tumors as a Translational Model for Human Breast Cancer

  2020cites this paper
• Circular RNA hsa_circ_0000376 Participates in Tumorigenesis of Breast Cancer by Targeting miR-1285-3p

  2020cites this paper
• Asociación de variantes genéticas en el gen DEAR1 con cáncer de seno y desenlace clínico en población colombiana

  2020cites this paper
• NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.

  2020cites this paper
• Text Mining Of Variant-Genotype-Phenotype Associations From Biomedical Literature

  2020cites this paper
• Mobile element insertions and associated structural variants in longitudinal breast cancer samples

  2020cites this paper
• CRISPR–Cas9/long-read sequencing approach to identify cryptic mutations in BRCA1 and other tumour suppressor genes

  2020cites this paper
• Genetic Testing for Hereditary Breast and Ovarian Cancer and Li-Fraumeni

  2020cites this paper
• FEP Medical Policy Manual FEP 2.04.02 Genetic Testing for BRCA1 or BRCA2 for Hereditary Breast/Ovarian Cancer Syndrome and Other High-Risk Cancers

  2020cites this paper